methyl 2-hydroxy-4-oxo-4-(pyridin-4-yl)but-2-enoate, 95+%, 250mg

2-(4-(Benzyloxy)-3,5-dimethylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 97%, 5g

5-Bromo-2-trifluoromethyl-pyridin-3-ylamine, 98%, 100mg

4-((3-(aminomethyl)pyridin-2-yl)oxy)cyclohexan-1-one oxalate, 95.0%, 1g

2-(1,3-Benzodioxol-5-yl)-4,6-bis(trichloromethyl)-1,3,5-triazine>98.0%(GC)25g

2-Methylheptan-3-one, 95.0%, 5g

(3-Aminopyridin-2-yl)methanol, 95.0%, 100mg

BIS(1,1-DIMETHYLETHYL)(3-BROMOPROPYL) IMIDODICARBONATE, 95.0%, 1g

MonoVinyl Terminated Polydimethylsiloxanes-asymmetric cSt 80-120, 100g

3-Bromo-1-methylpyridin-2(1H)-one, 95.0%, 5g

4,5-Dibromo-1H-pyrrole-2-carboxylic acid, 95.0%, 100mg

Di(N-succinimidyl) L-Tartrate50mg

1-(trifluoroacetyl)-4-piperidinecarboxylic acid, 95.0%, 5g